Clinical Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T Injection in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Study Summary

This study is a single-center clinical study. The main purpose is an IIT clinical trial to evaluate the safety and preliminary efficacy of CLL1 and CD38 dual CAR-T injection in r/r AML subjects . The included population were patients with relapsed and refractory acute myeloid leukemia (r/r AML) .

Interventions

Study Locations

Facility	City	State	Country
920th Hospital of Joint LogisticsSupport Force of People's Liberation	Kunming	Yunnan	China

Official Trial Information

View on ClinicalTrials.gov